Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025
Modular Medical (NASDAQ:MODD) has announced an upcoming webinar presentation featuring CEO Jeb Besser, scheduled for May 28, 2025, at 9 a.m. Pacific / 12 p.m. Eastern. The presentation, titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy," will focus on the company's FDA-cleared patch pump technology designed for "almost-pumpers." The company addresses a significant market opportunity, with 1.9 million Type 1 Diabetes patients in the US, where currently only one-third use insulin pumps despite 100% requiring daily insulin injections. The event will be hosted by Tribe Public's Managing Member John F. Heerdink, Jr., and will include a Q&A session.
Modular Medical (NASDAQ:MODD) ha annunciato un webinar in programma con il CEO Jeb Besser, previsto per il 28 maggio 2025 alle 9:00 ora del Pacifico / 12:00 ora dell'Est. La presentazione, intitolata "Rendere più semplice la gestione del diabete: la nuova era della terapia insulinica", si concentrerà sulla tecnologia del patch pump approvata dalla FDA, pensata per gli "quasi utilizzatori di pompe". L'azienda si rivolge a un'importante opportunità di mercato, con 1,9 milioni di pazienti con diabete di tipo 1 negli Stati Uniti, dove attualmente solo un terzo utilizza pompe per insulina nonostante il 100% necessiti di iniezioni quotidiane di insulina. L'evento sarà condotto da John F. Heerdink, Jr., membro dirigente di Tribe Public, e includerà una sessione di domande e risposte.
Modular Medical (NASDAQ:MODD) ha anunciado un próximo seminario web con el CEO Jeb Besser, programado para el 28 de mayo de 2025 a las 9 a.m. hora del Pacífico / 12 p.m. hora del Este. La presentación, titulada "Hacer más simple el manejo de la diabetes: la nueva era de la terapia con insulina", se centrará en la tecnología de parche bomba aprobada por la FDA, diseñada para "casi usuarios de bombas". La compañía aborda una gran oportunidad de mercado, con 1.9 millones de pacientes con diabetes tipo 1 en EE. UU., donde actualmente solo un tercio usa bombas de insulina a pesar de que el 100% requiere inyecciones diarias de insulina. El evento será presentado por John F. Heerdink, Jr., miembro gerente de Tribe Public, e incluirá una sesión de preguntas y respuestas.
Modular Medical (NASDAQ:MODD)는 CEO Jeb Besser가 참여하는 웨비나를 2025년 5월 28일 오전 9시 태평양 시간 / 정오 동부 시간에 개최할 예정이라고 발표했습니다. "당뇨병 관리 간소화: 인슐린 치료의 새로운 시대"라는 제목의 발표에서는 FDA 승인을 받은 패치 펌프 기술에 대해 다룰 예정이며, 이는 '거의 펌프 사용자'를 위한 것입니다. 이 회사는 미국 내 190만 명의 제1형 당뇨병 환자라는 큰 시장 기회를 겨냥하고 있으며, 현재 100%가 매일 인슐린 주사가 필요함에도 불구하고 단지 3분의 1만 인슐린 펌프를 사용하고 있습니다. 행사는 Tribe Public의 매니징 멤버 John F. Heerdink, Jr.가 진행하며 질의응답 시간도 포함됩니다.
Modular Medical (NASDAQ:MODD) a annoncé un prochain webinaire avec le PDG Jeb Besser, prévu le 28 mai 2025 à 9h00 heure du Pacifique / 12h00 heure de l'Est. La présentation, intitulée « Simplifier la gestion du diabète : la nouvelle ère de la thérapie à l'insuline », portera sur la technologie du patch pump approuvée par la FDA, conçue pour les « quasi-utilisateurs de pompes ». L'entreprise s'adresse à une opportunité de marché importante, avec 1,9 million de patients atteints de diabète de type 1 aux États-Unis, où actuellement seulement un tiers utilise des pompes à insuline alors que 100 % nécessitent des injections quotidiennes d'insuline. L'événement sera animé par John F. Heerdink, Jr., membre dirigeant de Tribe Public, et comprendra une session de questions-réponses.
Modular Medical (NASDAQ:MODD) hat ein bevorstehendes Webinar mit CEO Jeb Besser angekündigt, das für den 28. Mai 2025 um 9 Uhr Pazifikzeit / 12 Uhr Eastern geplant ist. Die Präsentation mit dem Titel "Diabetes-Management einfacher machen: Die neue Ära der Insulintherapie" konzentriert sich auf die von der FDA zugelassene Patch-Pump-Technologie, die für "Fast-Pumpen-Nutzer" entwickelt wurde. Das Unternehmen adressiert eine bedeutende Marktchance mit 1,9 Millionen Typ-1-Diabetes-Patienten in den USA, von denen derzeit nur ein Drittel Insulinpumpen verwendet, obwohl 100 % tägliche Insulininjektionen benötigen. Die Veranstaltung wird von John F. Heerdink, Jr., geschäftsführendes Mitglied von Tribe Public, moderiert und beinhaltet eine Fragerunde.
- None.
- None.
Meet with Modular Medical CEO Jeb Besser
There are 1.9 million individuals with Type 1 Diabetes in the US.
100% of patient population require daily insulin injection. Only 1 out of 3 currently use an insulin pump.Discover how Modular Medical is developing technology to empower the whole diabetes community with MODD1
Register at MODD-Therapy.TribePublic.com
SAN DIEGO, CA / ACCESS Newswire / May 27, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, today announced that Jeb Besser, CEO of Modular Medical, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy."The Event is scheduled to begin at 9 a.m. pacific / 12 p.m. eastern on Wednesday, May 28, 2025. To register to join the complimentary event, please visit the Tribe Public LLC at MODD-Therapy.TribePublic.com.
Once registered, participants may begin forwarding their questions for the CEO to Tribe Public at research@tribepublic.com or share their questions via the ZOOM chat feature during the event. Tribe Public's Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management.
About Modular Medical
Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
ABOUT TRIBE PUBLIC LLC
Tribe Public LLC, headquartered in San Francisco, California, is a distinguished organization that facilitates corporate sponsored global webinars and in-person meetings events across 36 premier venues throughout the United States. Tribe Public's events are tailored to address topics of significant interest to its members, with a particular emphasis on providing direct access to management teams and leading experts from diverse sectors who seek to enhance awareness of their products, achievements, and strategic initiatives. The Tribe's membership is composed primarily of Family Offices, Portfolio Managers, Registered Investment Advisors, Accredited Investors, Sell Side Analysts, and media professionals, all of whom benefit from exclusive opportunities for business development, community building, and informed dialogue in a collegial setting. Members are actively encouraged to shape the event agenda by submitting speaker and company preferences through Tribe Public's complimentary "Wish List" process on its website, ensuring that the programming reflects the evolving interests of its sophisticated community. To learn more about Tribe Public's offerings and to participate in upcoming events, visit their website at: http://www.tribepublic.com/
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Modular Medical (MODD) CEO's presentation scheduled for May 2025?
What is the market size for Type 1 Diabetes patients in the US according to Modular Medical (MODD)?
What is the title of Modular Medical (MODD) CEO's Tribe Public webinar?
How can investors register for Modular Medical's (MODD) May 2025 webinar?
What is Modular Medical's (MODD) main product focus?
